Upadacitinib trials for Crohn's disease

All Upadacitinib trials · All Crohn's disease trials

Phase breakdown

Recruiting trials studying Upadacitinib for Crohn's disease

• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
  NCT06227910 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 138 locations
• Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
  NCT06332534 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 85 locations
• Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease
  NCT06780683 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 12 locations
• Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease
  NCT06902987 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response
  NCT07510191 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Upadacitinib for Crohn's disease?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.